[Federal Register Volume 85, Number 54 (Thursday, March 19, 2020)]
[Notices]
[Pages 15814-15815]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05748]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Ainistration
[Docket No. DEA-591]
Bulk Manufacturer of Controlled Substances Application: Siegfried
USA, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before May 18, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 6, 2019, Siegfried USA, LLC, 33 Industrial
Park Road, Pennsville, New Jersey 08070-3244 applied to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Dihydromorphine........................ 9145 I
Hydromorphinol......................... 9301 I
Methylphenidate........................ 1724 II
Amobarbital............................ 2125 II
Pentobarbital.......................... 2270 II
Secobarbital........................... 2315 II
Codeine................................ 9050 II
Oxycodone.............................. 9143 II
[[Page 15815]]
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Opium tincture......................... 9630 II
Oxymorphone............................ 9652 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for sale to its customers.
Dated: February 10, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-05748 Filed 3-18-20; 8:45 am]
BILLING CODE 4410-09-P